International Vaccine Institute (IVI) is an international organization devoted to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children, in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 30 countries throughout Asia, Africa and Latin America on epidemiological and disease surveillance, and clinical studies of vaccines against enteric and diarrheal infections, Japanese encephalitis, MERS-CoV, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit www.ivi.int. IVI is the lead grantee for the CAPTURA consortium.
Public Health Surveillance Group (PHSG), LLC, is a global health consulting group based in the United States. PHSG provides services and support to initiatives in public health surveillance, global health security, research, and monitoring & evaluation. The group strives to improve health systems and generate reliable, high quality data to equip decision makers with the information necessary to reduce morbidity and mortality across Asia and Africa. PHSG collaborates with leading public health organizations as well as local governments in over 20 countries to enhance vertical and integrated surveillance strategies and systems.
The WHONET, development team is based within the Division of Infectious Disease of the Brigham and Women’s Hospital, Boston, a nonprofit teaching hospital affiliated with Harvard Medical School. The team has developed, disseminated, and supported the WHONET software since 1989. WHONET supports local, national, and regional antimicrobial resistance surveillance initiatives in over 2,300 hospital, public health, veterinary, and food laboratories in over 120 countries. The group actively participates in the development and implementation of activities and guidelines of the World Health Organization (WHO), the European Antimicrobial Resistance Surveillance Network (EARS-Net), the US Centers for Disease Control and Prevention, and the Clinical and Laboratory Standards Institute (CLSI), among others.
The Big Data Institute is located in the Li Ka Shing Centre for Health Informatics and Discovery at the University of Oxford. It is an interdisciplinary research centre that focuses on the analysis of large, complex data sets for research into the causes, consequences, prevention and treatment of disease. Research is conducted in areas such as genomics, population health, infectious disease surveillance and the development of new analytic methods. The Big Data Institute is supported by funding from the Medical Research Council, the UK Research Partnership Investment Fund, the National Institute for Health Research Oxford Biomedical Research Centre, and philanthropic donations from the Li Ka Shing and Robertson Foundations.